Home › Funds › HANCOCK WHITNEY CORP › JNJ

HANCOCK WHITNEY CORP position in JNJ

JOHNSON JOHNSON · Health Care

HANCOCK WHITNEY CORP reported holding 218,107 shares of JNJ (JOHNSON JOHNSON) in its Q2 2026 13F filing — a position valued at US$55.4M, representing 0.92% of its reported portfolio and ranking #22 among its reported holdings. HANCOCK WHITNEY CORP has disclosed JNJ holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)218.11K sh
Reported value held$55.39M
Portfolio Weight0.92%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How HANCOCK WHITNEY CORP's JNJ position evolved

HANCOCK WHITNEY CORP first disclosed a stake in JNJ in Q3 2023 at 56,961 shares (US$8.9M). The position peaked in Q2 2026 at 218,107 shares, worth US$55.4M. Across 12 filings, HANCOCK WHITNEY CORP increased the stake 4 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 218,107 shares valued at US$55.4M — a reduction of -4,786 shares quarter over quarter.. Notable position changes include a 369% increase in Q2 2025 (shares rose 22% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 56.96K $8.87M New
Q4 2023 55.46K $8.69M Reduce
Q1 2024 53.24K $8.42M Reduce
Q2 2024 51.63K $7.55M Reduce
Q3 2024 52.45K $8.50M Add
Q4 2024 53.85K $7.79M Add
Q1 2025 54.74K $9.08M Add
Q2 2025 256.93K $39.25M Add
Q3 2025 239.69K $44.44M Reduce
Q4 2025 231.03K $47.81M Reduce
Q1 2026 222.89K $53.72M Reduce
Q2 2026 218.11K $55.39M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has HANCOCK WHITNEY CORP held JNJ?

HANCOCK WHITNEY CORP has disclosed JNJ holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is HANCOCK WHITNEY CORP's current position in JNJ?

As of Q2 2026, HANCOCK WHITNEY CORP holds 218.11K shares of JNJ (JOHNSON JOHNSON), valued at $55.39M, representing 0.92% of its reported portfolio and ranking #22.

Has HANCOCK WHITNEY CORP been buying or selling JNJ?

In the latest 13F filing (Q2 2026), HANCOCK WHITNEY CORP reduced its position in JNJ. The position peaked in Q2 2026 at 218.11K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.